SpringWorks Therapeutics Financials
SWTXDelisted Stock | USD 46.99 0.00 0.00% |
SpringWorks |
Please note, the imprecision that can be found in SpringWorks Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SpringWorks Therapeutics. Check SpringWorks Therapeutics' Beneish M Score to see the likelihood of SpringWorks Therapeutics' management manipulating its earnings.
SpringWorks Therapeutics Stock Summary
SpringWorks Therapeutics competes with Revolution Medicines, Blueprint Medicines, Stoke Therapeutics, Cytokinetics, and Relay Therapeutics. SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. SpringWorks Therapeutics, Inc. was founded in 2017 and is headquartered in Stamford, Connecticut. Springworks Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people.Specialization | Healthcare, Biotechnology |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US85205L1070 |
CUSIP | 85205L107 |
Location | Connecticut; U.S.A |
Business Address | 100 Washington Boulevard, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.springworkstx.com |
Phone | 203 883 9490 |
Currency | USD - US Dollar |
SpringWorks Therapeutics Key Financial Ratios
SpringWorks Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SpringWorks Therapeutics's current stock value. Our valuation model uses many indicators to compare SpringWorks Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SpringWorks Therapeutics competition to find correlations between indicators driving SpringWorks Therapeutics's intrinsic value. More Info.SpringWorks Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SpringWorks Therapeutics' earnings, one of the primary drivers of an investment's value.SpringWorks Therapeutics Market Pulse
Quote | 46.99 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 46.99 |
Low | 46.98 |
High | 47.01 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as SpringWorks Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of SpringWorks has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if SpringWorks Therapeutics' financials are consistent with your investment objective using the following steps:- Review SpringWorks Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand SpringWorks Therapeutics' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare SpringWorks Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if SpringWorks Therapeutics' stock is overvalued or undervalued.
SpringWorks Therapeutics July 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of SpringWorks Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of SpringWorks Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of SpringWorks Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing SpringWorks Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build SpringWorks Therapeutics's daily price indicators and compare them against related drivers.
Downside Deviation | 3.69 | |||
Information Ratio | (0.02) | |||
Maximum Drawdown | 20.32 | |||
Value At Risk | (6.92) | |||
Potential Upside | 5.93 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in SpringWorks Stock
If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |